Sichuan Difeite Pharmaceutical

Sichuan Difeite Pharmaceutical is a specialized pharmaceutical company focused on the development and large-scale manufacture of taxane-based oncology treatments. Headquartered in Guanghan, China, the company is a leading global producer of high-purity active pharmaceutical ingredients (APIs) including Paclitaxel, Docetaxel, and Cabazitaxel. Difeite operates state-of-the-art GMP-certified facilities dedicated to plant extraction and semi-synthetic chemical processes, serving both domestic and international pharmaceutical markets. In addition to its API portfolio, the company produces finished sterile injections and key intermediates such as 10-DAB III, positioning itself as a critical supplier in the global cancer drug supply chain.